deltatrials
Completed OBSERVATIONAL NCT05443867

Monkeypox ASymptomatic Shedding: Evaluation by Self-Sampling MPX-ASSESS (MPX-Assess)

Sponsor: Institute of Tropical Medicine, Belgium

Conditions Monkey Pox
Updated 5 times since 2022 Last updated: Sep 28, 2023 Started: Jun 22, 2022 Primary completion: Aug 25, 2022 Completion: Aug 25, 2022
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Monkey Pox, this trial is completed. The trial is conducted by Institute of Tropical Medicine, Belgium and has accumulated 5 data snapshots since 2022. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Sep 2022 – ~Oct 2023 · 13 months · monthly snapshotRecruiting~Oct 2023 – ~Jul 2024 · 9 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotCompleted~Sep 2025 – present · 10 months · monthly snapshotCompleted

Change History

5 versions recorded
  1. Sep 2025 — Present [monthly]

    Completed

  2. Sep 2024 — Sep 2025 [monthly]

    Completed

  3. Jul 2024 — Sep 2024 [monthly]

    Completed

  4. Oct 2023 — Jul 2024 [monthly]

    Completed

    Status: RecruitingCompleted

  5. Sep 2022 — Oct 2023 [monthly]

    Recruiting

    First recorded

Jun 2022

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Institute of Tropical Medicine, Belgium
Data source: Institute of Tropical Medicine, Belgium

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations